Incidence, risk factors and outcomes of seizures occurring after craniotomy for primary brain tumor resection.

Neurosciences (Riyadh)

Intensive Care Department, King Abdulaziz Medical City, Riyadh, Kingdom of Saudi Arabia. E-mail:

Published: April 2017

Objective: To determine the incidence, risk factors and outcomes of early post-craniotomy seizures.

Methods: This was a retrospective cohort study of all patients who underwent craniotomy for primary brain tumor resection (2002-2011) and admitted postoperatively to the intensive care unit. The patients were divided into 2 groups depending on the occurrence of seizures within 7 days.

Results: One-hundred-ninety-three patients were studied: 35.8% had preoperative seizure history and 16.6% were on prophylactic antiepileptic drugs (AEDs). Twenty-seven (14%) patients had post-craniotomy seizures. The tumors were mostly meningiomas (63% for the post-craniotomy seizures group versus 58.1% for the other group; p=0.63) and supratentorial (92.6% for the post-craniotomy seizures versus 78.4% for the other group, p=0.09) with tumor diameter=3.7+/-1.5 versus 4.2+/-1.6 cm, (p=0.07). One (3.1%) of the 32 patients on prophylactic AEDs had post-craniotomy seizures compared with 12% of the 92 patients not receiving AEDs preoperatively (p=0.18). On multivariate analysis, predictors of post-craniotomy seizures were preoperative seizures (odds ratio, 2.62; 95% confidence interval, 1.12-6.15) and smaller tumor size <4 cm (odds ratio, 2.50; 95% confidence interval, 1.02-6.25). Post-craniotomy seizures were not associated with increased morbidity or mortality.

Conclusion: Early seizures were common after craniotomy for primary brain tumor resection, but were not associated with worse outcomes. Preoperative seizures and smaller tumor size were independent risk factors.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726815PMC
http://dx.doi.org/10.17712/nsj.2017.2.20160570DOI Listing

Publication Analysis

Top Keywords

post-craniotomy seizures
20
incidence risk
8
risk factors
8
factors outcomes
8
seizures
8
craniotomy primary
8
primary brain
8
brain tumor
8
tumor resection
8
post-craniotomy
6

Similar Publications

Article Synopsis
  • The study aimed to compare the effectiveness and safety of sodium valproate (VPA) versus levetiracetam (LEV) in treating severe traumatic brain injury (sTBI) in 84 patients.
  • Both treatment groups showed similar improvements in neurological function and clinical outcomes, with no significant differences in hospital stay or seizure occurrence after 3 months.
  • However, the VPA group had a higher rate of drug-related adverse reactions (40.48%) than the LEV group (21.43%), suggesting that LEV may be a safer option for treating sTBI.
View Article and Find Full Text PDF

Superiority of levetiracetam over phenytoin for postcraniotomy seizure prophylaxis in patients with a supratentorial brain tumor is controversial. We aimed to evaluate the efficacy of levetiracetam versus phenytoin for postcraniotomy seizure prophylaxis in supratentorial brain tumor. In a randomized controlled trial study, 80 patients with a supratentorial brain tumor who underwent craniotomy were allocated to levetiracetam or phenytoin group, 40 patients each.

View Article and Find Full Text PDF

Objectives The study aims to correlate craniotomies and their effect on epileptic activity and to assess the impact of prophylaxis anti-epileptic drugs (AEDs) used to prevent seizure activity after craniotomy. Method This was a mono-center retrospective review of patients undergoing craniotomy from 2010-2021 at King Abdulaziz University Hospital (KAUH), a tertiary center in Jeddah, Saudi Arabia. The patients were divided into two groups depending on preoperative anti-epileptic drug usage and the occurrence of seizures after the surgery.

View Article and Find Full Text PDF

Purpose: Deficits in neuro-cognitive function are not uncommon for patients who have undergone surgical removal of brain tumors. Our goal is to evaluate the safety and efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) as a non-invasive tool for the treatment of neuro-cognitive dysfunctions following craniotomy.

Methods: We present a retrospective review of individualized rTMS in twelve patients from Cingulum Health from December 2019 to July 2021 who presented with neuro-cognitive deficits following craniotomy.

View Article and Find Full Text PDF

The use of prophylactic antiepileptic medication and driving restrictions for craniotomies among Australian and New Zealand neurosurgeons.

J Clin Neurosci

September 2022

Department of Neurosurgery, Princess Alexandra Hospital, 199 Ipswich Rd, Woolloongabba, QLD 4102, Brisbane, Australia; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.

Prophylactic antiepileptic drug (pAED) use for craniotomy surgery is currently not supported in literature [1-5] except possibly in traumatic brain injury (TBI) [6]. Post craniotomy driving restrictions using the Austroad guidelines are based upon literature on TBI and not specifically craniotomy [16-18]. This study was to review Australian and New Zealand neurosurgeons on their use of pAED and advice on driving restrictions post craniotomy surgery.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!